The Venture Codex Logo

The Venture Codex

Overview

Single-cell technologies for new therapeutics in difficult diseases.

Total Raised

$17 M

Rounds

2

Links

Verticals

Biotechnology
Life Science
Oncology
Therapeutics

Investment History

  1. Series A

    Jul 2025

    $17M

Team

David Schilansky

Co-Founder & CEO

Magali Richard

Deputy CEO and co-founder

Céline Vallot

Scientific Founder

Romain LETOURNEUR

General Counsel & DPO